Diligence memo · auto-generated · as of July 2, 2026
Cure, Inc.
Cure, Inc. looks under-valued against its niche peers and is quiet on financing cadence.
Businessfiled
Cure, Inc. operates in Other, based in NEW YORK.
Sector still resolves to a broad 'Other' bucket, so operating comparables below are weaker than for a tightly-classified peer.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
Cure, Inc. has raised $8.8M in disclosed capital across 6 recorded rounds, aggregated from public filings. Its latest round is modeled as Seed (a $1.0M–$4.0M round).
Largest single filing: $3.0M on 2022-08-15.
Most recent recorded round closed around 2024-09-09.
Valuation (modeled)modeled
Provath models Cure, Inc. at approximately $5.9M (range $1.4M–$15M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Under-valued. Modeled value is 0.52× the median modeled value of Seed Other companies in 2022–2024 (1231 peers) — value vs value, same stage and era.
Financing rhythm & timingmixed
Historic cadence: a new round about every 15 months.
Last raise 22 mo ago; this sector typically re-raises about every 11 months.
Slightly overdue versus sector cadence.
The last round stepped up 4.1× from the prior — scaling.
Comparablesmixed
Capital scale ranks ahead of 75% of Other peers (25015 compared).
Modeled value ranks above 28% of those peers.
Closest niche peers: Dropee Inc., NFH Northern Project Development, LLC, FactorFund-Note-2022 LLC, Immersion Elements LLC, Possip, Inc..
Peoplefiled
1 named person on file across officers, directors and signatories.
Risks & flagsmixed
Broad sector classification weakens peer comparison.
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.